$SNPS

Synopsys And OpenAI Team Up On GPT-Synopsys

Synopsys and OpenAI partnered to create GPT-Synopsys, sharing revenue based on AI-driven chip design improvements. Synopsys raised its fiscal 2027 revenue growth outlook to 15%, exceeding analyst estimates. The deal introduces value-based pricing but maintains traditional verification steps, reducing AI replacement risk.

Original reporting
Published Sep 30, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys And OpenAI Team Up On GPT-Synopsys — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The partnership may create a new monetization stream and improve design cycle times, supporting the raised guidance.

02

Market read

Guidance lift and AI partnership are likely to move SNPS higher in the near term.

03

What to watch

Implementation risk and potential pushback from customers accustomed to traditional licensing.

Relevance 8/10Novelty 8/10Timing: today

Background

Synopsys, a leading electronic design automation company, is teaming with OpenAI to embed GPT‑based models into its workflow, tying revenue to AI usage.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced a partnership with OpenAI and raised its fiscal 2027 revenue growth outlook to 15%, above analyst estimates.

Expected impact

upward pressure as investors price in stronger growth outlook

Evidence & confidence

The new 15% growth target beats consensus and introduces a revenue‑share model that could boost margins.

Market effects

AI‑enabled EDA tools may accelerate adoption across semiconductor design firms.

U.S. tech sector could see modest uplift from the partnership news.

Highlights growing AI integration in hardware design worldwide.

Counterpoint

Revenue‑share model could introduce volatility if AI usage fluctuates.

Key entities

  • Synopsys

    Electronic design automation provider

  • OpenAI

    AI research and deployment organization

Related articles

$SNPSMed

Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

Synopsys (NASDAQ: SNPS) updated its long-term growth targets at its 2026 Investor Day, expecting fiscal year 2027 revenue of $11.15 billion (15% YoY growth). The company plans to return up to 50% of free cash flow to shareholders via share repurchases, aiming to buy back $1 billion in shares. Synopsys highlighted AI-driven demand and partnerships, including a deal with Amazon and a collaboration with OpenAI for AI-powered chip design.

$SNPSMed

Synopsys (SNPS) Partners with OpenAI to Integrate AI into Semico

Synopsys (SNPS) announced a multi-year partnership with OpenAI to develop GPT-Synopsys, an AI-driven model for semiconductor design. The collaboration aims to optimize workflows and includes a revenue-sharing agreement. SNPS is trading at $432, 34.4% below its GF Value™ of $658.56, with a GF Score™ of 91. Insider activity shows $48.2M in sales over the past year.

$SNPSHighAI 9/10

Synopsys stock analysis: what does today’s news tell investors?

Synopsys Inc (SNPS) stock rose 4.97% to $435.70 after announcing a $1B+ multi-year deal with Amazon.com (AMZN) for silicon IP licensing. The deal introduces a new license-plus-royalty model. Additionally, Synopsys partnered with OpenAI to develop GPT-Synopsys for semiconductor design. CEO Sassine Ghazi raised FY2027 revenue growth guidance to 15%, above analyst consensus of 11.19%.

$SNPSHigh

Synopsys shares jump on GPT-Synopsys chip design deal with OpenAI

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, an AI model for chip design. Synopsys shares rose 4.19% to $435.50 on the news, part of a 9.94% climb over 20 trading sessions. The deal involves revenue sharing and software licensing, but financial terms were not disclosed. Synopsys reported quarterly revenue of $2.48bn and net income of $545.8m for the quarter ended 31 July 2026.